Literature DB >> 1475958

Pseudothrombocytopenia in a child with the acquired immunodeficiency syndrome.

V K Wong1, R Robertson, G Nagaoka, E Ong, L Petz, E R Stiehm.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1475958      PMCID: PMC1022109     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  18 in total

1.  Platelet aggregation and pseudothrombocytopenia induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand's disease patient.

Authors:  A Casonato; F Fabris; A Girolami
Journal:  Eur J Haematol       Date:  1990-07       Impact factor: 2.997

2.  Platelet aggregation induced by type IIb platelet von Willebrand factor.

Authors:  H R Gralnick; L P McKeown; S Williams; C Jenneau; Y Sultan; J van Mourik
Journal:  Br J Haematol       Date:  1989-02       Impact factor: 6.998

3.  Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin.

Authors:  D P Shreiner; W R Bell
Journal:  Blood       Date:  1973-10       Impact factor: 22.113

4.  Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia.

Authors:  D I Abrams; D D Kiprov; J J Goedert; M G Sarngadharan; R C Gallo; P A Volberding
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391

5.  Thrombocytopenia as the presenting manifestation of human T-lymphotropic virus type III infection in infants.

Authors:  F T Saulsbury; R J Boyle; R F Wykoff; T H Howard
Journal:  J Pediatr       Date:  1986-07       Impact factor: 4.406

6.  Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.

Authors:  R E McKinney; P A Pizzo; G B Scott; W P Parks; M A Maha; S N Lehrman; M Riggs; J Eddy; B A Lane; S C Eppes
Journal:  J Pediatr       Date:  1990-04       Impact factor: 4.406

7.  Response to therapy in 37 patients with HIV-related thrombocytopenic purpura.

Authors:  E Oksenhendler; P Bierling; J P Farcet; C Rabian; M Seligmann; J P Clauvel
Journal:  Br J Haematol       Date:  1987-08       Impact factor: 6.998

8.  Pseudothrombocytopenia: a cold autoantibody against platelet glycoprotein GP IIb.

Authors:  H H van Vliet; M C Kappers-Klunne; J Abels
Journal:  Br J Haematol       Date:  1986-03       Impact factor: 6.998

9.  Recognition and prevention of pseudothrombocytopenia and concomitant pseudoleukocytosis.

Authors:  A J Lombarts; W de Kieviet
Journal:  Am J Clin Pathol       Date:  1988-05       Impact factor: 2.493

10.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

View more
  1 in total

Review 1.  Pseudothrombocytopenia-A Review on Causes, Occurrence and Clinical Implications.

Authors:  Benjamin Lardinois; Julien Favresse; Bernard Chatelain; Giuseppe Lippi; François Mullier
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.